Fact 19 of 20 in the story · Saturday 14 November, 07h19

Wegovy : une Gersoise témoigne de sa perte de poids

Alors que l'arrivée du Wegovy en comprimés suscite des interrogations dans les pharmacies du Gers, une habitante de Fleurance raconte comment elle a perdu 30 kilos sans opération ni médicament.

In brief

Health event (severity: info) in Fleurance (Gers), first detected on 14 November 2026 at 07:19. Reported by 1 source (1 article), last updated on 14 November 2026 at 07:19. Part of the story “Anti-obesity GLP-1 in France: reimbursement, diverted uses and health alerts”.

Category: Health
Severity: Info
Place: 32 GersFleurance
Detected: 14 Nov, 07h19
Updated: 14 Nov, 07h19
Reference: no.19461

What changed in the story at that point

Just before11h05 · −4 j

Une campagne anti-grossophobie de Lilly France soupçonnée de publicité déguisée pour le Mounjaro

Low· Health · no.15163

Here · 07h19

Just after09h00 · +1 h 41

Wegovy et Mounjaro remboursés : les centres spécialisés de l'obésité saturés

Low· Health · no.19512

Who is covering it, and from what angle

Method

1Left

1 article · 1 source · 1 bord sur 3 · outlets: left 1, centre 0, right 0

Story angles

This event does not yet have its own comparison: here is the story's Anti-obesity GLP-1 in France: reimbursement, diverted uses and health alerts.

All three sides cover the arrival of Wegovy in tablet form, but the left emphasizes industrial competition and reimbursement conditions, the center develops waiting times, the parallel market and patient testimonies, while the right highlights the non-reimbursable nature and practical information (price, side effects).

Left

Highlights the rivalry between Novo Nordisk and Eli Lilly on a fast-growing global market, as well as the lack of reimbursement for pills and side effects to be aware of.

Centre

Develops concrete consequences: waiting times of up to 18 months, parallel market, position of drug treatments compared with bariatric surgery and patient testimonies.

Right

Emphasizes the non-reimbursable nature of oral Wegovy and offers a practical format listing price, side effects and reimbursement.

Common points

=Wegovy in tablet form is available in pharmacies in France from Monday, November 2
=The oral version is not reimbursed
=Wegovy had until now been administered by injection in France

Divergences

≠The left emphasizes competition between laboratories (Novo Nordisk, Eli Lilly), an angle little present on the right
≠The center insists on waiting times of up to 18 months and the parallel market, absent from the left and right titles provided
≠The center and right detail price and side effects in a practical format, the left favoring the industrial and regulatory angle

Written by an AI from headlines and extracts only of all events in the story · 2 Nov, 03h41

Lire les sources · 1 article, 1 source

Publication order

07h19
La Dépêche du MidiCentre-leftReport14 Nov
TÉMOIGNAGE. "Je ne voulais ni opération ni médicament" : face à l'arrivée du Wegovy, cette Gersoise raconte comment elle a perdu 30 kilos
Alors que l'arrivée annoncée du Wegovy, un médicament anti-obésité, sous forme de comprimés suscite des interrogations dans les pharmacies du Gers, une habitante de Fleurance raconte comment elle est parvenue à perdre...

Wegovy : une Gersoise témoigne de sa perte de poids

What changed in the story at that point

Who is covering it, and from what angle

Lire les sources · 1 article, 1 source

Further reading